Cerity Partners
PLYX icon

Cerity Partners’s Polaryx Therapeutics Inc PLYX Stock Holding History

Cerity Partners’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.6K Buy
+10,427
New +$22.7K ﹤0.01% 3397

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $225B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Cerity Partners's PLYX Position: Q3 2026 in Review

Cerity Partners opened a new position in Polaryx Therapeutics Inc (PLYX) in Q3 2026: 10,427 shares worth $21.6K. The stake represents ﹤0.01% of the portfolio and ranks #3397 among its holdings.

11 funds tracked by Wall St. Rank hold PLYX as of Q3 2026.

  • Cerity Partners held 10,427 shares of Polaryx Therapeutics Inc worth $21.6K as of Q3 2026.
  • Polaryx Therapeutics Inc was a new Cerity Partners position in Q3 2026.
  • Polaryx Therapeutics Inc made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #3397 holding.
  • 11 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.